Citations

Clear

1828 citation(s) found for "Su, Emily".

540: COMPARISON OF INITIAL SEDATION AND ANALGESIA IN PATIENTS ON BUPRENORPHINE VS OPIOID-NAIVE PATIENTS
Piotrowicz, Anna, Bektas, Aeryana, Casey, Emily, Uritsky, Tanya, Yagnala, Nikitha , Bektas, Aeryana N., Uritsky, Tanya J.

Mayo Clinic

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001184156.17432.d6 Get It

Abstract B035: Integrating RNA sequencing and spatial transcriptomic analyses reveals drivers of glioblastoma malignancy near the brains’ lateral ventricles
Gonzalez-Aponte, Maria F. , Salazar, Jhan C., Figueroa-Gonzalez, Aura, Suarez-Meade, Paola, Guerrero-Cázares, Hugo, Salazar, Jayson, Norton, Emily S. , Meade, Paola Suarez, Guerrero‐Cazares, Hugo

Mayo Clinic

Cancer Research | March 23, 2026 | Volume: 86 | Issue: 6_Supplement | Pages: B035-B035

10.1158/1538-7445.brain26-b035 Get It

Abstract Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults with a poor prognosis of 15 months despite aggressive therapies. GBM malignancy is often driven by a high degree of inter- and intra-tumoral heterogeneity that is dynamic through time and regulated by interactions between tumor cells and their neural microenvironment. For instance, GBM tumors located near the lateral ventricles (LV) of the brain grow more aggressively and result in significantly worse patient survival, compared to tumors that grow far from the LV. This suggests that interactions between GBM and cells in the LV microenvironment may regulate tumor malignancy. Understanding the mechanisms underlying GBM malignancy near the LV is essential to determine if regulation of tumor biology is driven by the presence of healthy neural cells, and to ultimately develop therapeutic approaches that target GBM-LV interactions. Here, we tested the hypothesis that region-specific cellular identities and activation of unique transcriptional programs regulate GBM malignancy near the LV. Paired primary biopsies were collected from 14 GBM patients. Image-guided biopsies proximal and distal to the brain’s LV (LV-proximal GBM and LV-distal GBM, respectively) were processed for bulk RNA sequencing, single-nucleus RNA sequencing, and in situ spatial transcriptomic (Xenium) analyses. We found significant inter-patient and intra-tumoral transcriptional heterogeneity in GBM samples collected proximal and distal to the LV. After accounting for tumoral and patient heterogeneity, we found that proximal GBM tumors exhibit an increased immune-related gene signature, compared with tumors distal to the LV. Single-nucleus RNA sequencing and in situ spatial transcriptomic analyses showed no significant differences in the proportion of cellular states or identities between proximal and distal GBM samples. However, within each cellular identity, significant differences in gene expression were identified between proximal and distal GBM, suggesting that distinct cell-specific transcriptional pathways characterize regional differences in GBM biology. Our results suggest that GBM tumors near the LV have increased interactions with immune cells that lead to the enrichment of immune-related transcriptional pathways, compared to tumors growing far from the LV. This work will inform the development of therapies that target GBM-immune cell interactions to decrease tumor malignancy and improve individual patient outcomes. Citation Format: Maria F. Gonzalez-Aponte, Jhan C. Salazar, Aura Figueroa-Gonzalez, Emily S. Norton, Paola Suarez-Meade, Hugo Guerrero-Cazares. Integrating RNA sequencing and spatial transcriptomic analyses reveals drivers of glioblastoma malignancy near the brains’ lateral ventricles [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Brain Cancer; 2026 Mar 23-25; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2026;86(6_Suppl):Abstract nr B035.
Emergencies in palliative medicine: novel simulation-based curriculum for end-of-life crises and symptom management
Yeow, Mei-Ean , Olson, Emily A. , Wiste, Rachel M., Huschka, Mashele , Asirvatham, Usha, Rhee, Laura S., Olson, Emily , Wiste, Rachel , Rhee, Laura

Mayo Clinic

BMJ Supportive & Palliative Care | March 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: spcare-2025-005936

10.1136/spcare-2025-005936 | PMID 41871932 Get It

Hospice and palliative medicine (HPM) simulation training primarily focuses on communication skills, rather than symptom management. Simulation can be an effective educational tool in high stakes clinical settings and provides a safe environment to improve skills in crisis management. HPM providers are often called to manage refractory symptoms in emotionally charged situations, especially at end-of-life care. These scenarios may present infrequently during their 1-year fellowship training. We describe a novel two-part simulation series ‘End of Life Symptom Management: Emergencies in Palliative Medicine’ that we have developed for our interdisciplinary HPM Fellowship. Our simulation series is conducted at our institution’s simulation centre and includes scenarios of (1) refractory pain, (2) palliative sedation, (3) initiation of buprenorphine-naloxone for cancer-associated pain in a patient with opioid use disorder (OUD), (4) acute pain crisis in a hospice patient with OUD on buprenorphine-naloxone, (5) terminal delirium, (6) compassionate extubation/respiratory distress, (7) status epilepticus and (8) terminal haemorrhage. Pre and postsession data collected from our HPM fellows reflect an increase in confidence levels after participating in the sessions. This simulation curriculum has allowed our fellows the opportunity to encounter and navigate these scenarios in a safe and controlled learning environment before encountering them in practice.
Effect of Hand Size on Forearm Muscle Activity While Using Laparoscopic Instruments
Olig, Emily M. , Wilson, S., Keole, Nandita , Yi, J., Buras, Matthew , Wilson, S.

Mayo Clinic

Obstetrics & Gynecology | March 20, 2026 | Volume: 147 | Issue: 4S | Pages: 6S-7S

10.1097/aog.0000000000006204.6 Get It

Barriers, Facilitators, and Attitudes Toward Telemedicine Adoption in Oncology: A Qualitative Study of Patients From Low-Broadband Areas
Sharma, Pravesh , Kamath, Celia , Jeno, Sarah E., Breutzman, Emily, Brockman, Tabetha A. , Haddad, Tufia C. , Pritchett, Joshua C. , Sharma, Pravesh , Kamath, Celia C , Breutzman, Emily N., Patten, Christi A. , Haddad, Tufia C , Pritchett, Joshua , Brockman, Tabetha A

Mayo Clinic

JCO Oncology Practice | March 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-25-01155 | PMID 41861270 Get It

PURPOSE Limited access to high-speed internet (broadband [BB]) may pose challenges to video telehealth visit (VTV) utilization. This study explored barriers, facilitators, and attitudes toward VTV adoption in patients with cancer residing in low-BB settings. METHODS We examined a cohort of patients with cancer receiving longitudinal care at Mayo Clinic Cancer Practice in the Upper Midwest. Eligible patients had ≥6 in-person visits during July 2020-October 2022, received oncology care at Mayo Clinic sites, were alive at sampling, and resided in low-BB areas defined by Federal Communications Commission data as 0 or 1 internet service provider offering <25 Mbps. We enrolled 24 participants stratified into two groups: (1) Transitioned users (TUs): adopted VTVs postpandemic (November 2022-December 2023); (2) persistent nonusers (PNUs): received exclusively in-person visits. Semistructured telephone interviews were conducted in June 2024 and thematically analyzed. RESULTS The average age of participants was 71.3 years (range, 42-88), 50% was female, and all identified as White. Three themes emerged: (1) Structural and clinical constraints—physical examinations, laboratory testing, and chemotherapy administration were viewed as requiring in-person care, whereas VTVs were perceived acceptable for routine follow-ups; (2) Skills and experience—digital literacy was generally adequate, but confidence and direct exposure to VTV distinguished TU from PNU; (3) Motivations—both groups preferred in-person care for cancer-related emotional reassurance. TU cited weather, travel burden, and proactive provider offering as adoption triggers, whereas PNU reported that VTV was rarely offered. TU focused on system-level solutions, whereas PNUs preferred individual-level resources. CONCLUSION Differential VTV adoption in low-BB settings reflected exposure, provider offering, and situational necessity rather than BB access alone. Oncology practices should consider normalizing the hybrid care model combining in-person and video appointment visits and provide tailored supports to advance equitable telemedicine. Expanding video care in oncology requires more than digital access and depends on patient experience, care context, and human connection inherent in oncology care.
Pediatric hospitalizations related to sports participation: a 10-year comparative analysis across 18 commonly played sports in the United States
Schluttenhofer, Adam, Ross, Emily S., Smock, Cameron S. , Radel, Luke C. , Soma, David, Schluttenhofer, Adam , Schluttenhofer, Adam , Soma, David A, Ross, Emily S.

Mayo Clinic

The Physician and Sportsmedicine | March 19, 2026 | Volume: 54 | Issue: 4 | Pages: 295-302

10.1080/00913847.2026.2648482 | PMID 41854496 Get It

Deep Learning–based Monoenergetic Imaging for Calcified Coronary Stenosis Assessment at Energy-integrating Detector CT
Chang, Shaojie , Koons, Emily K. , Gong, Hao , Thorne, Jamison E. , Williamson, Eric E. , Foley, Thomas A. , McCollough, Cynthia H., Leng, Shuai, McCollough, Cynthia H. , Leng, Shuai , McCollough, Cynthia H , Leng, Shuai , Williamson, Eric , Thorne, Jamison E , Gong, Hao

Mayo Clinic

Radiology: Cardiothoracic Imaging | March 19, 2026 | Volume: 8 | Issue: 2 | Pages: No page available

10.1148/ryct.250230 | PMID 41854396 Get It

A deep learning–based neural network enabled virtual monoenergetic imaging at energy-integrating detector CT, reduced blooming artifacts, and improved stenosis assessment in heavily calcified coronary plaques, with performance comparable to ultrahigh-resolution photon-counting detector CT.
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival
Ekstrom, Thomas L. , Dai, Zhangshuai , Thiel, Julia , Kanakan, Akshay , Saha, Bishakha Joyeeta , Manjunath, Meghana, Schacherer, Nadine , Bousounis, Pavlos , Siegler, Emily L. , Abdelrahman, Amro M. , Essmann, Frank, Beyes, Sven , Truty, Mark J. , Dong, Meng, Johnsen, Steven A. , Dong, Meng , Manjunath, Meghana , Essmann, Frank , Beyes, Sven , Truty, Mark J , Johnsen, Steven A , Abdelrahman, Amro M , Souto, Yara , Najafova, Zeynab , Dong, Meng

Mayo Clinic

Science Advances | March 18, 2026 | Volume: 12 | Issue: 12 | Pages: No page available

10.1126/sciadv.aea2106 | PMID 41849608 Get It

Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal cancer with a 5-year survival rate of 13%. Despite recent molecular stratification of tumors into distinct classical and basal-like cell states, most tumors are heterogeneous and contain both subtypes. Therefore, therapeutic approaches targeting only one subtype are unlikely to be effective as standalone PDAC treatments. Here, we integrated chromatin accessibility [assay for transposase-accessible chromatin with sequencing (ATAC-seq)], genome-wide occupancy [chromatin immunoprecipitation sequencing (ChIP-seq)] for epigenetic status (H3K27ac), and H3K4me3-anchored chromatin topology (HiChIP) to uncover subtype-independent highly interactive enhancers that interact with essential genes in PDAC. Motif analysis revealed that these common enhancers were bound by KLF5 with subsequent depletion leading to decreased cell viability via induction of apoptosis. To elucidate the transcriptional and epigenetic mechanisms by which KLF5 functions in PDAC, we used rapid depletion of KLF5 with dTAG technology and profiled the effects on the open and active chromatin landscape and transcription with nascent RNA and messenger RNA sequencing over time. Enhancer inactivation via KRAB domain Zim3-dCas9 fusion protein confirmed KLF5-bound enhancers regulate target genes, including the anti-apoptotic gene BCL2L1 . Multiplex immunofluorescence confirmed costaining of KLF5 and Bcl-xL in patient samples and overexpression of Bcl-xL rescued the induction of apoptosis after KLF5 depletion. Together, this study provides insights into common mechanisms to target highly heterogeneous PDAC tumors.
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma
Tasdemir, Nilgun , Scott, Julie A., Biery, Kyle, Li, Zheqi , Bossart, Emily A., Wang, Sarah , Nasrazadani, Azadeh , Qin, Ye Jun, Cao, Ye , Castro, Carlos A. , Davidson, Nancy E. , Oesterreich, Steffi, Li, Zheqi , Tseng, George , Hooda, Jagmohan , Lee, Adrian V , Savariau, Laura , Latoche, Joseph D. , Sreekumar, Sreeja , Brown, Daniel D. , Watters, Rebecca Jean , Chen, Fangyuan , Sikora, Matthew J. , Anderson, Carolyn J. , Atkinson, Jennifer M. , Lucas, Peter C. , Lee, Adrian V. , Oesterreich, Steffi

Mayo Clinic

No container title available | March 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.17.712396 | PMID 41890029 Get It

Invasive lobular breast carcinoma (ILC), the most common special histological subtype of breast cancer, is characterized by nearly universal expression of estrogen receptor alpha (ER) and unique sites of metastases, neither of which is fully recapitulated by genetically engineered mouse models. Using reporter-labeled ILC mouse xenografts, herein we used mammary fat pad, tail vein and intracardiac orthotopic growth to analyze spontaneous and experimental metastasis and gene expression. We observed ER-positive primary tumors with single-file histology and collagen deposition, and spontaneous metastasis from the mammary fat pad to bones, ovaries, and brain including the leptomeninges, thereby closely mirroring the growth and metastatic spread of human ILC. Brain metastases showed strong ER staining, confirmed by sequencing analyses which identified estrogen signaling as top activated pathway, and the lesions exhibited robust response to endocrine therapy. In summary, we report endocrine responsive mammary fat pad, tail vein and intracardiac xenografts that faithfully demonstrate unique ILC features and can serve as invaluable pre-clinical translational platforms for validating candidate ILC genetic drivers and testing novel therapeutics.